Reishi (Ganoderma lucidum) is a medicinal mushroom used in traditional Chinese medicine, containing bioactive compounds including polysaccharides, triterpenoids, and beta-glucans. It functions primarily as an immunomodulator, with antioxidant, anti-inflammatory, and adaptogenic properties that support immune function, stress response, and overall wellness. Commonly used as a daily supplement for immune support, sleep quality, anxiety reduction, and general health promotion.

Overview

Reishi (Ganoderma lucidum), known as Ling Zhi in Chinese and Mannentake in Japanese, is a polypore mushroom that has been used in East Asian medicine for over 2,000 years, earning the epithet "mushroom of immortality" and "herb of spiritual potency." Unlike culinary mushrooms, reishi is woody and bitter, consumed exclusively for its medicinal properties. Its bioactive constituents fall into two principal categories: triterpenes (ganoderic acids), which are responsible for the bitter taste and many pharmacological effects, and polysaccharides (particularly beta-glucans), which drive its immunomodulatory activity. Over 400 bioactive compounds have been identified in reishi, including sterols, peptidoglycans, and nucleotides, making it one of the most pharmacologically complex medicinal mushrooms alongside lion's mane and turkey tail.

Reishi's immunomodulatory properties are its best-characterized clinical attribute. Beta-glucans and other polysaccharides activate dendritic cells, macrophages, and natural killer (NK) cells through pattern recognition receptors including Dectin-1 and TLR-2, enhancing innate immune surveillance. Simultaneously, reishi modulates adaptive immunity by influencing T-cell differentiation — promoting regulatory T-cell activity while modulating Th1/Th2 balance, which gives it both immune-enhancing and immune-calming properties depending on context. This bidirectional immunomodulation supports its use in both immune deficiency and autoimmune conditions. Ganoderic acids contribute anti-inflammatory effects through inhibition of NF-kB, histamine release, and 5-alpha-reductase (the enzyme that converts testosterone to DHT), as well as hepatoprotective activity and direct cytotoxic effects against certain cancer cell lines. Clinical studies in cancer patients have shown that reishi supplementation can improve quality of life, enhance immune markers, and increase NK cell activity when used as adjunctive therapy alongside conventional treatment.

Beyond immunity, reishi demonstrates adaptogenic properties — supporting the hypothalamic-pituitary-adrenal (HPA) axis and enhancing resilience to physical and psychological stress. It has traditional and emerging evidence for sleep quality improvement, anxiety reduction, cardiovascular support (including blood pressure regulation and lipid modulation), and blood sugar management. Reishi extracts are available as hot-water extracts (polysaccharide-rich), alcohol extracts (triterpene-rich), or dual-extracted products that capture both compound classes. Typical supplemental dosing ranges from 1.5-9 grams/day of dried mushroom equivalent or 1-1.5 grams/day of concentrated extract. Quality and potency vary widely between products — look for extracts standardized to both polysaccharide and triterpene content. Reishi pairs well with other medicinal mushrooms and adaptogens including cordyceps, ashwagandha, and astragalus.

Mechanism of Action

Reishi mushroom (Ganoderma lucidum) contains over 400 bioactive compounds, with its therapeutic effects primarily attributed to two major classes: polysaccharides (beta-glucans) and triterpenoids (ganoderic acids). Beta-glucans, particularly β-1,3/1,6-D-glucans, activate innate immunity by binding to pattern recognition receptors on immune cells, including Dectin-1, complement receptor 3 (CR3), and Toll-like receptors (TLR-2, TLR-4) on macrophages, dendritic cells, and natural killer (NK) cells. This triggers downstream NF-κB and MAPK signaling cascades, enhancing phagocytosis, cytokine production (IL-2, IL-6, IL-10, TNF-α, IFN-γ), and NK cell cytotoxicity.

Ganoderic acids and other triterpenoids exert anti-inflammatory effects by inhibiting NF-κB activation, suppressing COX-2 and iNOS expression, and reducing histamine release from mast cells. These triterpenoids also demonstrate direct anticancer activity by inhibiting topoisomerase II, inducing cell-cycle arrest, and triggering mitochondrial-mediated apoptosis through modulation of the Bcl-2 family proteins and caspase cascade. Ganoderic acid T has been shown to inhibit tumor invasion by suppressing MMP-9 expression via the MAPK/ERK pathway. The polysaccharides improve insulin sensitivity through activation of the AMPK pathway and modulate gut microbiota composition, influencing the gut-brain and gut-liver axes. Additionally, Ganoderma lucidum spore oil contains triterpenes that exhibit hepatoprotective effects by enhancing antioxidant enzyme activity (SOD, CAT, GPx) and reducing lipid peroxidation through Nrf2/ARE pathway activation (Ekiz et al., Foods 2023).

Reconstitution Calculator

Research

Safety Profile

Safety Profile: Reishi (Ganoderma lucidum)

Common Side Effects

• Gastrointestinal upset including nausea, diarrhea, stomach discomfort, and dry mouth
• Dizziness and headache, particularly during initial use
• Skin itching and rash, especially with high-dose or concentrated extracts
• Dry mouth and throat irritation
• Nosebleeds reported in some users (possibly related to antiplatelet effects)
• Insomnia or vivid dreams at higher doses

Serious Adverse Effects

• Hepatotoxicity: Multiple case reports of clinically significant liver injury, including one fatal case; powdered reishi products have been implicated; liver function monitoring recommended with long-term use
• Bleeding complications: Triterpenes and polysaccharides inhibit platelet aggregation; clinically significant bleeding events reported
• Severe allergic reactions and anaphylaxis (rare)
• Chronic use of powdered whole mushroom linked to more adverse effects than hot-water extracts
• Potential immunostimulation may exacerbate autoimmune conditions

Contraindications

• Known allergy to reishi or other Ganoderma species
• Active bleeding disorders or patients on therapeutic anticoagulation
• Upcoming surgery (discontinue at least 2 weeks prior due to antiplatelet effects)
• Active autoimmune diseases without medical supervision (immune-stimulating polysaccharides, particularly beta-glucans)
• Pregnancy and lactation (insufficient safety data)
• Active liver disease or history of drug-induced liver injury

Drug Interactions

• Anticoagulants/Antiplatelets (warfarin, aspirin, clopidogrel, heparin): Significant additive bleeding risk due to antiplatelet triterpenes; INR monitoring essential
• Antihypertensives: Ganoderic acids may lower blood pressure; monitor for hypotension
• Immunosuppressants (cyclosporine, tacrolimus, prednisone): Beta-glucan immunostimulation may counteract immunosuppressive therapy
• Antidiabetic agents: May potentiate hypoglycemia; blood glucose monitoring recommended
• Hepatotoxic drugs: Additive liver injury risk; avoid concurrent use with other hepatotoxic agents (acetaminophen at high doses, methotrexate, etc.)
• Chemotherapy: Mixed evidence; may enhance or interfere with certain agents; use only under oncologist guidance

Population-Specific Considerations

• Elderly: Monitor liver function, blood pressure, and bleeding signs; start with lower doses
• Pediatric: Not recommended for children due to lack of safety data
• Cancer patients: Widely used as adjunctive therapy in East Asia; discuss with oncologist; may improve quality of life but evidence for tumor outcomes is limited
• Liver disease patients: Avoid or use only under close hepatological supervision given hepatotoxicity reports
• Transplant recipients: Avoid due to immunostimulatory potential conflicting with immunosuppressive regimens

Pharmacokinetic Profile